Sumera I. Ilyas

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Emilien Loeuillard, Jingchun Yang, EeeLN H. Buckarma et al. · Journal of Clinical Investigation · 2020 · 393 citations · Full text

Medicine, Immunology, Oncology +17

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist et al. · Hepatology · 2022 · 370 citations

Medicine, Pathology, Radiology +17

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma

Domenico Alvaro, Gregory J. Gores, Joël Walicki et al. · Journal of Hepatology · 2023 · 298 citations · Full text

Medicine, Oncology, Radiology +14

IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism

Daisaku Yamada, Sumera I. Ilyas, Nataliya Razumilava et al. · Hepatology · 2015 · 139 citations · Full text

Medicine, Oncology, Pathobiology +14

PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II

Liankang Sun, Yuanguo Wang, Xianghu Wang et al. · Cell Reports · 2022 · 54 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15